The serum levels of MMP-2 correlated significantly with serum levels of TIMP-2 in colorectal cancer patients (p < 0.001) and intensity of this protein expression in inflammatory (p = 0.012) and normal colorectal cells (p = 0.039). This evidence concerns the gene MMP2 and colorectal cancer.